Nika Pharmaceuticals, Inc (NIKA) — 10-K Filings
All 10-K filings from Nika Pharmaceuticals, Inc. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (3)
-
NIKA Cuts Losses by 20% Amid Strategic Pharma Pivot, Faces Going Concern
— Mar 25, 2026 Risk: high
NIKA PHARMACEUTICALS, INC. (NIKA) reported a net loss of $76,398 for the fiscal year ended December 31, 2025, a 20.25% improvement from the $95,792 net loss in -
Nika Pharmaceuticals Files 2024 10-K
— Mar 31, 2025 Risk: low
Nika Pharmaceuticals, Inc. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, previously known as Centen -
NIKA PHARMACEUTICALS, INC. Files 2023 Annual Report on Form 10-K
— Apr 1, 2024 Risk: low
NIKA PHARMACEUTICALS, INC (NIKA) filed a Annual Report (10-K) with the SEC on April 1, 2024. Nika Pharmaceuticals, Inc. filed its annual report on Form 10-K for
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX